SpaceX: $1.75T IPO And 220x EV/EBITDA Could Trigger Surge In Aerospace And Defense

SpaceX is reportedly targeting a $1.75 trillion IPO valuation, implying a substantial premium to current aerospace and defense sector multiples. The valuation assumes about 30% annual growth with expanding EBITDA margins through 2030, which could support a broader rerating of both pure-play space and traditional defense stocks if the IPO is successful.

Analysis

A marquee IPO priced at a nosebleed multiple does more than re-rate one name; it changes the comp set. The first-order beneficiaries are not just the obvious space peers, but any adjacent platform business with credible exposure to launch cadence, satellite payloads, ground infrastructure, and high-reliability electronics, because public-market investors will be forced to anchor on a new valuation regime rather than legacy defense EV/EBITDA. The bigger second-order effect is on capital formation: if primary capital can be raised against multi-year growth at premium multiples, private competitors will be incentivized to spend harder, not rationalize, which raises the probability of a prolonged spend cycle across the space stack.

The market is likely underestimating how much this can reprice the traditional defense cohort even if they have limited direct space economics. A successful deal would signal that investors are willing to underwrite long-duration government-adjacent growth with software-like multiples, which can spill into satellites, ISR, missile defense, and launch-adjacent industrials. The beneficiaries should be the names with clean narratives around backlog, margin expansion, and visible growth inflection; the losers are the low-growth primes with bloated pension/liability overhangs and no credible exposure to the new growth bucket.

The key risk is timing: the rerating may happen at filing/marketing rather than pricing, then fade if the deal clears only after heavy retail enthusiasm or if secondary supply overwhelms the tape post-IPO. Also, a large success case can paradoxically hurt near-term sentiment for the broader ecosystem if investors conclude that every private space asset is now “too expensive” and public comps are forced to justify even higher bars. The contrarian read is that this is less about intrinsic value and more about financing optionality; if rates stay high or the IPO window narrows, the premium can compress quickly, turning the narrative from growth endorsement into dilution scare.

Key Decisions for Investors

• Put on a 3-6 month pair: long high-quality defense/space enablers with visible backlog and margin leverage vs short low-growth traditional primes that lack space exposure. The trade works if the IPO catalyzes a comp rerating but capital flows concentrate in the better growers.
• Buy call spreads on a basket of pure-play space beneficiaries over the next 1-2 quarters into IPO marketing windows. Use defined risk because the initial rerating can be sharp, but post-pricing supply and lockup concerns can cap upside.
• Fade the most obvious sympathy move in overowned defense names if they gap on the headline: sell into strength or use put spreads for 1-3 months. The best risk/reward is in names where the market is extrapolating a valuation halo without earnings leverage.
• If filing data confirms margin expansion and durable growth assumptions, rotate toward suppliers with pricing power rather than launch-only exposure. Those names should benefit across multiple IPO outcomes, not just this one.
• Set a trigger to reduce risk if the IPO implies a valuation that the broader market starts applying to all space assets without differentiating quality. That would be the point where the rerating becomes crowded and the upside-to-downside skew worsens.